Literature DB >> 9557998

Clinical value of vaginal cones for the management of female stress incontinence.

K Kato1, A Kondo.   

Abstract

In women with mild stress incontinence (mean urine loss of 3.7 g/h), pelvic floor training using vaginal cones resulted in a subjective success rate of 70% (19/27), that is complete cure or reduction by >50% of the original severity. However, in women with severe stress incontinence (mean urine loss of 20.7 g/h) cone therapy was successful in only 14% (7/50). The predictive value of six parameters (age, parity, urine loss by pad test, frequency of incontinence, contractile strength of the vagina, and perceived problems) was analyzed and two showed significant prognostic values: a smaller amount of urine loss and less frequent incontinence. It is concluded that vaginal cone therapy is one physical treatment option for stress incontinence but is of no clinical effect for those with severe incontinence.

Entities:  

Mesh:

Year:  1997        PMID: 9557998     DOI: 10.1007/BF02765492

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  11 in total

1.  Effectiveness of vaginal cones in treatment of urinary incontinence.

Authors:  K Moore; J B Metcalfe
Journal:  Urol Nurs       Date:  1992-06

2.  Progressive resistance exercise in the functional restoration of the perineal muscles.

Authors:  A H KEGEL
Journal:  Am J Obstet Gynecol       Date:  1948-08       Impact factor: 8.661

3.  Vaginal cones for the treatment of genuine stress incontinence.

Authors:  P D Wilson; M Borland
Journal:  Aust N Z J Obstet Gynaecol       Date:  1990-05       Impact factor: 2.100

4.  [Pelvic floor muscle training as treatment of stress incontinence. The effectiveness of vaginal cones].

Authors:  K Kato; A Kondo; S Hasegawa; M Saito; Y Yamada; T Murase; K Miyake
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1992-04

5.  [Prevalence of urinary incontinence in working women].

Authors:  K Kato; A Kondo; K Okamura; H Takaba
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1986-09

6.  [Urinary incontinence in women: results of questionnaires].

Authors:  J Fukui
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1986-05

7.  Vaginal cones: a conservative method of treating genuine stress incontinence.

Authors:  A B Peattie; S Plevnik; S L Stanton
Journal:  Br J Obstet Gynaecol       Date:  1988-10

8.  Testing and training of the pelvic floor muscles after childbirth.

Authors:  A Jonasson; B Larsson; H Pschera
Journal:  Acta Obstet Gynecol Scand       Date:  1989       Impact factor: 3.636

9.  Bladder neck support prosthesis: a nonoperative treatment for stress or mixed urinary incontinence.

Authors:  A Kondo; E Yokoyama; K Koshiba; J Fukui; M Gotoh; Y Yoshikawa; T Yamada; M Takei
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

10.  Treatment of stress incontinence by vaginal cones: short- and long-term results and predictive parameters.

Authors:  A Kondo; Y Yamada; R Niijima
Journal:  Br J Urol       Date:  1995-10
View more
  4 in total

1.  Static and dynamic MRI of a urinary control intra-vaginal device.

Authors:  A J Maubon; M P Boncoeur-Martel; V Juhan; C R Courtieu; A S Thurmond; P Aubas; P Marès; J P Rouanet
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

2.  Initial experience with a new method for the dynamic assessment of pelvic floor function in women: the Kolpexin Pull Test.

Authors:  Nathan Guerette; Minda Neimark; Stacy L Kopka; Jacob E Jones; G Willy Davila
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-01-09

3.  Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability.

Authors:  G Willy Davila
Journal:  Adv Urol       Date:  2011-06-23

4.  Vaginal cone use in passive and active phases in patients with stress urinary incontinence.

Authors:  Jorge Milhem Haddad; Ricardo Muniz Ribeiro; Wanderley Marques Bernardo; Maurício Simões Abrão; Edmund Chada Baracat
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.